NCT02432807View on ClinicalTrials.gov

Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis

PHASE3CompletedINTERVENTIONAL

Enrollment

303

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions

Bacterial Conjunctivitis

Interventions

DRUG

Vancomycin 1.1%

Vancomycin hydrochloride ophthalmic ointment 1.1%

DRUG

Placebo

Trial Locations (16)

Unknown

Paramount

Petaluma

Rancho Cordova

Deerfield Beach

Waterloo

Newton

Pittsburg

Shawnee Mission

Havre de Grace

St Louis

Asheville

High Point

Cincinnati

Roseburg

Spartanburg

Memphis

All Listed Sponsors

lead

Kurobe LLC

INDUSTRY

NCT02432807 - Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis | Biotech Hunter | Biotech Hunter